The Albumin in Acute Stroke (ALIAS) Multicenter Clinical Trial: Safety Analysis of Part 1 and Rationale and Design of Part 2 - Ginsberg, Myron D.; Palesch, Yuko Y.; Martin, Renee H.; Hill, Michael D.; Moy, Claudia S.; Waldman, Bonnie D.; Yeatts, Sharon D.; Tamariz, Diego; Ryckborst, Karla (Stroke (1970), 2011)
Keywords: Age Factors; Aged; Aged, 80 and over; Biological and medical sciences; Cohort Studies; Diuretics - administration & dosage; Female; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy; Humans; Male; Medical sciences; Middle Aged; Nervous system (semeiology, syndromes); Neurology; Serum Albumin - administration & dosage; Serum Albumin - adverse effects; Stroke - blood; Stroke - mortality; Stroke - therapy; Thrombolytic Therapy; Time Factors; Troponin - blood; Vascular diseases and vascular malformations of the nervous system; Cerebral infarction; Stroke; Nervous system diseases; Multicenter study; Albumin; Cardiovascular disease; Cerebral disorder; randomized controlled trial; Vascular disease; neuroprotectant; Central nervous system disease; Brain ischemia; Cerebrovascular disease; ischemic stroke